Welcome to Pathway Medical Technologies

JETSTREAM® products are now part of the Radiology & Interventional business of Bayer HealthCare.

Click here to see our other Interventional Solutions

Pathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies. An estimated 12 million people are afflicted by PAD in the United States, and this number is projected to grow to over 20 million people during the next 10 years. The JETSTREAM Navitus^™ System includes a revascularization catheter which allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing hard and soft plaque, calcium, thrombus, and fibrotic lesions.

MEDRAD, Inc., a business of Bayer HealthCare (BHC) and part of the Radiology and Interventional business unit, acquired Pathway Medical Technologies, Inc. in the third quarter of 2011. Pathway Medical Technologies, Inc. was merged into MEDRAD, Inc. on March 31, 2012.

Indications for use: The JETSTREAM ^® System is intended for use in atherectomy of the peripheral vasculature and to break apart and remove thrombus from upper and lower extremity peripheral arteries. It is not intended for use in coronary, carotid, iliac or renal vasculature. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.